FDA Orange Book
Is there a generic for Izervay?
Izervay contains avacincaptad pegol. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Izervay (avacincaptad pegol). The Orange Book shows its last listed patent expires July 11, 2034.
Run it in Rivvi
Map Izervay and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Izervay products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution, intravitreal | EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) | Marketed (Rx) | None | 0 | None |
NDA 217225, held by ASTELLAS PHARMA US INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Izervay patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 8236773 | November 11, 2026 | Method of use | U-3673 | 217225 |
| 9617546 | February 14, 2027 | Drug substance | U-3673 | 217225 |
| 7579456 | February 14, 2027 | Drug substance | None | 217225 |
| 11491176 | July 11, 2034 | Method of use | U-3673 | 217225 |
| 11273171 | July 11, 2034 | Method of use | U-3673 | 217225 |
| 12016875 | July 11, 2034 | Method of use | U-3673 | 217225 |
Izervay NDC codes
Questions
Is there a generic for Izervay?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Izervay (avacincaptad pegol). The Orange Book shows its last listed patent expires July 11, 2034.
What is the generic name for Izervay?
The active ingredient in Izervay is avacincaptad pegol, per the FDA Orange Book.
When does the Izervay patent expire?
The last patent listed for Izervay in the Orange Book expires July 11, 2034. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.